Our work showed that KLF6 was more significantly down-regulated in HCC specimens than in the adjacent tissues and that this down-regulation correlated with the survival rate of HCC patients, indicating that KLF6 may serve as a new prognostic biomarker in HCC. This evidence concerns the gene KLF6 and hepatocellular carcinoma.